Evolution of the Average Target: BioNTech SE

Evolution of the Average Target - BioNTech SE

Evolution of the Target Price: BioNTech SE

Evolution of the Target Price - BioNTech SE

Changes in Analyst Recommendations: BioNTech SE

e4a9c68e8d343f.7cGdSuCMNSCS2EbnhwTbh2WTnR9F62GCTgpK8piMQ8A.p6rWBqztRBWlkhyW73W3qjDDz2ownxe3Pz5yhOnKALCHqM0Jr8VeePjpEw~835b4a9e67ddf5af3317ef52229a7ca8
19/11 BioNTech SE : JP Morgan reiterates its Neutral rating ZD
04/11 UBS Adjusts Price Target on BioNTech to $125 From $135, Keeps Buy Rating MT
04/11 BioNTech SE : Gets a Buy rating from UBS ZD
04/11 BioNTech: Q3 beat; sales guidance narrowed upwards; incoming CEO could shift gears Alphavalue
04/11 BioNTech SE : Jefferies remains its Buy rating ZD
27/10 BioNTech SE : JP Morgan gives a Neutral rating ZD
26/10 BioNTech SE : UBS reiterates its Buy rating ZD
09/10 BofA Adjusts Price Target on BioNTech to $114 From $122, Keeps Buy Rating MT
08/10 Argus Research Initiates Coverage on BioNTech SE With Hold Rating MT
07/10 BioNTech SE : Gets a Buy rating from Berenberg ZD
16/09 Berenberg Raises Price Target on BioNTech to $140 From $132, Keeps Buy Rating MT
16/09 BioNTech SE : UBS maintains a Buy rating ZD
16/09 BioNTech SE : Jefferies keeps its Buy rating ZD
16/09 BioNTech SE : Berenberg gives a Buy rating ZD
15/09 BioNTech SE : Jefferies maintains a Buy rating ZD
08/09 BMO Capital Downgrades BioNTech to Market Perform From Outperform, Adjusts PT to $105 From $128 MT
04/09 BioNTech SE : Goldman Sachs gives a Buy rating ZD
28/08 Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial MT
26/08 BioNTech SE : Deutsche Bank reiterates its Buy rating ZD
20/08 Cancer vaccines finally garner the spotlight Alphavalue
20/08 BioNTech SE : Jefferies keeps its Buy rating ZD
05/08 Berenberg Bank Adjusts BioNTech SE Price Target to $132 From $140, Maintains Buy Rating MT
05/08 BIONTECH : Berenberg reiterates its Buy rating ZD
05/08 BIONTECH : Gets a Buy rating from Jefferies ZD
05/08 BIONTECH : Bernstein sticks Neutral ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+37.81%
+40.13%
+18.8%
+8.94%
+17.72%
+24.48%
+29.56%
+72.29%
+19.97%
+34.42%
Average +30.41%
Weighted average by Cap. +28.81%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
73.74EUR
Average target price
102.18EUR
Spread / Average Target
+38.57%
High Price Target
130.93EUR
Spread / Highest target
+77.56%
Low Price Target
67.72EUR
Spread / Lowest Target
-8.16%

Analyst Consensus Detail

Analyst consensus - BioNTech SE

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BioNTech SE
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - BioNTech SE
  1. Stock Market
  2. Stocks
  3. BNTX Stock
  4. Consensus BioNTech SE